CDC Home

Updates to the Online Edition of CDC Health Information for International Travel 2012 (The Yellow Book)

This webpage contains a listing of the permanent changes made to the online text of CDC Health Information for International Travel 2012 since its May 2011 hardcopy release.

Changes are also indicated within the online sections.

Remember to also check for current recommendations related to outbreaks or emerging situations in Travel Notices that may differ temporarily from recommendations in the Yellow Book.

 

Content Changes
 

Updated malaria information for Burma (Myanmar) in Chapter 3, Yellow Fever & Malaria, by Country
October 15, 2012

We have updated the information regarding the areas in Burma (Myanmar) with malaria. Malaria is present at altitudes <1,000 m (3,281 ft). There is no malaria present in the cities of Mandalay and Rangoon (Yangoon). Country-specific malaria information can be found in Chapter 3, Yellow Fever & Malaria Information, by Country.

Updated yellow fever vaccination requirements for various countries in Chapter 3, Yellow Fever & Malaria Information, by Country
May 25, 2012

The World Health Organization has recently published changes to some countries’ yellow fever (YF) vaccination requirements. Many of these changes involve new guidance that YF vaccination is also required for people who are only transiting (making a brief stop or layover) in an airport located in a country with risk of YF virus transmission as part of their route to their final destination. These changes have been incorporated into the country-specific listing in Chapter 3, Yellow Fever & Malaria Information, by Country for the following countries:

Corrected contact information for US Fish and Wildlife Service
May 22, 2012

We have corrected the contact information for the US Fish and Wildlife Service (FWS) for travelers seeking information about importing certain animals in Chapter 6, Taking Animals & Animal Products across International Borders. The toll-free customer service line for FWS is 1-800-344-9453 (between 8:00 AM and 8:00 PM Eastern Time, Monday through Friday). Additional information about importing regulations can be found at http://www.fws.gov/le/ImpExp/Info_Importers_Exporters.htm

Updated information about polio vaccination for India (Chapter 3 and Chapter 4)
May 8, 2012

Poliomyelitis in Chapter 3 and India in Chapter 4 were updated to reflect the removal of the polio vaccine recommendation for India.

Updated malaria information for Bangladesh in Chapter 3, Yellow Fever & Malaria, by Country
April 26, 2012

We have updated the information regarding the areas in Bangladesh with malaria. Malaria is present in all areas, except in the city of Dhaka. Country-specific malaria information can be found in Chapter 3, Yellow Fever & Malaria Information, by Country.

Updated information about treatment of travelers' diarrhea in children (Chapter 2 and Chapter 7)
February 9, 2012

Travelers’ Diarrhea in Chapter 2 and Traveling Safely with Infants and Children in Chapter 7 were updated with additional information regarding the use of products containing bismuth subsalicylate for the treatment of travelers' diarrhea in children.

Updated yellow fever vaccine requirement for South Africa in Chapter 3, Yellow Fever & Malaria Information, by Country
February 7, 2012

South Africa’s National Institute for Communicable Diseases has confirmed that as of January 1, 2012, South Africa has added Eritrea to its list of countries for which yellow fever vaccination is required. We have updated the yellow fever vaccine requirements for South Africa in Chapter 3, Yellow Fever & Malaria Information, by Country.

Updated information on Meningococcal vaccine throughout the text
January 25, 2012

We have updated several places in the text to reflect the new recommendations for quadrivalent meningococcal conjugate vaccine (MenACWY-D) (Menactra, Sanofi Pasteur). In April 2011, the Food and Drug Administration approved the use of MenACWY-D as a 2-dose primary series among children aged 9–23 months. For more details about the recommendation, see Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease.

Vaccine recommendations have been updated in the Meningococcal Disease section in Chapter 3, the Vaccine Recommendations for Infants & Children section in Chapter 7, Table 2-01: Revaccination (booster) schedules, Table 2-03: Recommended and minimum ages and intervals between vaccine doses, Table 2-04: Vaccines described in the CDC Yellow Book and recommendations by ACIP, and Table C-01: Travel vaccine summary.

Updated yellow fever vaccine requirement for Zambia in Chapter 3, Yellow Fever & Malaria Information, by Country
December 30, 2011

The World Health Organization has confirmed that Zambia has changed its requirement for arriving travelers regarding yellow fever vaccination. We have updated the yellow fever vaccine requirements for Zambia in Chapter 3, Yellow Fever & Malaria Information, by Country.

Updated phone numbers for parasitic diseases and malaria inquiries
November 9, 2011

The phone number for inquiries about parasitic diseases has been changed from 770-488-7775 to 404-718-4745. The phone number has been updated in the following disease sections of Chapter 3: Angiostrongyliasis, Cyclosporiasis, Cutaneous Leishmaniasis, Visceral Leishmaniasis, Onchocerciasis, African Trypanosomiasis, and American Trypanosomiasis. The phone number has also been updated in the General Approach to the Returned Traveler section in Chapter 5.

In addition to the existing number for malaria inquiries (770-488-7788), there is now a toll free number available: 1-855-856-4713. Both malaria numbers are monitored Monday through Friday, 9 AM to 5 PM, Eastern Time. For clinicians needing emergency consultations after hours, the number remains the same: 770-488-7100; request to speak with a CDC Malaria Branch clinician. Sections referring to the malaria hotline have been updated to include the new toll-free number.

Added South Sudan to Chapter 3, Yellow Fever & Malaria Information, by Country
October 28, 2011

We added information specific to South Sudan to the Chapter 3, Yellow Fever & Malaria Information, by Country listing.

Updated information on mefloquine use in pregnant travelers
October 26, 2011

CDC has updated the information regarding mefloquine use during pregnancy. Because the Food and Drug Administration has reclassified mefloquine as pregnancy category B, cautionary language about mefloquine use during the first trimester has been removed. These changes are reflected in Chapter 3, Malaria and Chapter 8, Pregnant Travelers.

Updated information about human remains in Chapter 6, Death during Travel
October 25, 2011

We have updated the information about importing human remains of someone who died of any cause other than a quarantinable communicable disease in the Death during Travel section of Chapter 6.

Updated malaria information for Thailand in Chapter 3, Yellow Fever & Malaria, by Country
September 2, 2011

We have updated the information regarding the areas in Thailand with malaria. Malaria is present in rural, forested areas that border Burma (Myanmar), Cambodia, and Laos and in rural, forested areas in districts of Phang Nga and Phuket. Malaria is not in the cities of Bangkok, Chiang Mai, Chiang Rai, Koh Phangan, Koh Samui, Pattaya, Phang Nga, and Phuket. Additional country-specific malaria information can be found in Chapter 3, Yellow Fever & Malaria Information, by Country.

Updated yellow fever vaccine requirement for South Africa in Chapter 3, Yellow Fever & Malaria Information, by Country
September 1, 2011

We have updated the yellow fever vaccine requirement for South Africa in Chapter 3, Yellow Fever & Malaria Information, by Country with information provided by the government of South Africa. Changes in the requirement will be effective October 1, 2011.

Updated information on Japanese encephalitis vaccine throughout the text
September 1, 2011

We have updated several places in the text to reflect the fact that one of the Japanese encephalitis (JE) vaccines, JE-Vax, is no longer manufactured in the United States. JE-Vax was an inactivated mouse brain–derived vaccine manufactured by Biken and distributed by Sanofi Pasteur and was licensed in the United States in 1992 for use in travelers aged ≥1 year. In 2006, production of JE-Vax was discontinued, and all remaining doses expired in May 2011.

Information about JE-Vax has been removed from the Japanese Encephalitis section in Chapter 3, the Vaccine Recommendations for Infants & Children section in Chapter 7, Table 2-01: Revaccination (booster) schedules, Table 2-03: Recommended and minimum ages and intervals between vaccine doses, and Table C-01: Travel vaccine summary.

An inactivated Vero cell culture-derived JE vaccine (trade name Ixiaro) was licensed by the Food and Drug Administration on March 30, 2009, for use in the United Stated for travelers aged ≥17 years. The Ixiaro vaccine is not approved for use in children aged <17 years. Pediatric clinical trials are being conducted to enable licensure of Ixiaro for use in children. However, it will likely be several years before Ixiaro is licensed in the United States for use in children. For information about current options for obtaining JE vaccine for US children, see Update on Japanese Encephalitis (JE) Vaccine for US Children.

Updated malaria information for Bangladesh in Chapter 3, Yellow Fever & Malaria, by Country
August 25, 2011

We have updated the information regarding the areas in Bangladesh with malaria. Malaria is present in the eastern part of the country in the districts of Bandarban, Chittagong, Cox’s Bazar, Hobigonj, Khagrachari, Kurigram, Moulavibazar, Mymensingh, Netrokona, Rangamati, Sherpur, Sylhet, and Sunamgonj. Country-specific malaria information can be found in Chapter 3, Yellow Fever & Malaria Information, by Country.

Updated information about treatment of travelers' diarrhea in children (Chapter 7) and pregnant women (Chapter 8)
August 16, 2011

Traveling Safely with Infants and Children in Chapter 7 and Pregnant Travelers in Chapter 8 were updated with additional information regarding the use of products containing bismuth subsalicylate for the treatment of travelers' diarrhea in children and pregnant women.

Updated yellow fever vaccine requirements for India in Chapter 3, Yellow Fever & Malaria Information, by Country
August 1, 2011

Updates include the yellow fever vaccine requirements for India in Chapter 3, Yellow Fever & Malaria Information, by Country. We have updated the required age and the list of countries in Africa that India regards as countries and areas with risk of yellow fever virus transmission.

Updated information on interactions between oral typhoid vaccine and antimalarial drugs in Chapter 2, Drug-Vaccine & Drug-Drug Interactions
July 6, 2011

We have updated the Drug-Vaccine and Drug-Drug Interactions section in Chapter 2 to state that mefloquine, chloroquine, and atovaquone-proguanil can be given concurrently with oral typhoid vaccine.

Updated malaria information for Iguassu Falls in Chapter 4, Select Destinations
July 6, 2011

We have updated the Iguassu Falls section in Chapter 4 to state that there is no malaria transmission at Iguassu Falls. This is now consistent with the country-specific malaria information found in Chapter 3, Yellow Fever & Malaria Information, by Country.

Dexamethasone adult dose corrected
July 1, 2011

There is an error printed in the hardcopy for the dexamethasone adult dose used in preventing and treating altitude illness. The correct dose is 4 mg every 6 hours. We have corrected the dose in the online Yellow Book in Chapter 2, Altitude Illness.

Terminology change for malaria treatment regimens
July 1, 2011

The CDC Malaria Branch is introducing a new term of “reliable supply regimen” to replace the more commonly used term “standby emergency treatment regimen” or SBET. They believe this new term better reflects CDC’s recommendations for carrying a reliable supply of malaria medicines in certain rare circumstances as a treatment option, rather than emphasizing self-treatment of malaria. The term “reliable supply” refers to malaria medicines that are acquired in the home country, which are not likely to be counterfeit; are not likely to interact with concomitant medicines, including malaria chemoprophylaxis; will not deplete local medicine resources at the destination; and will be appropriate for potential drug resistance in the area. We have updated the online Yellow Book in Chapter 3, Malaria to reflect this terminology change. The CDC malaria website is located at: www.cdc.gov/malaria.

 

 
Contact Us:
  • Centers for Disease Control and Prevention
    1600 Clifton Rd
    Atlanta, GA 30333
  • 800-CDC-INFO
    (800-232-4636)
    TTY: (888) 232-6348
  • New Hours of Operation
    8am-8pm ET/Monday-Friday
    Closed Holidays
  • Contact CDC-INFO
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #